Seizert Capital Partners, LLC Emergent Bio Solutions Inc. Transaction History

Seizert Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$27.42 - $43.63 $1.07 Million - $1.7 Million	38,859 Added 61.18%	102,375 $3.18 Million
Q1 2022 May 03, 2022	BUY	$36.48 - $52.22 $1,860 - $2,663	51 Added 0.08%	63,516 $2.61 Million
Q4 2021 Feb 08, 2022	BUY	$33.11 - $55.01 $53,340 - $88,621	1,611 Added 2.6%	63,465 $2.76 Million
Q3 2021 Nov 03, 2021	BUY	$50.07 - $66.05 $1.8 Million - $2.38 Million	36,047 Added 139.68%	61,854 $3.1 Million
Q2 2021 Aug 05, 2021	BUY	$56.61 - $80.46 $1.46 Million - $2.08 Million	25,807 New	25,807 $1.63 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.